Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Drug-induced NASH].

Toshiji Saibara1, Saburo Onishi

  • 1Department of Gastroenterology and Hepatology, Kochi Medical School.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|June 14, 2006
PubMed
Summary
This summary is machine-generated.

Steatohepatitis involves liver fat accumulation and inflammation, often mimicking alcoholic hepatitis. This review categorizes pathways in drug-induced steatohepatitis, aiding differential diagnosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Dietary Oxysterol, 7-Ketocholesterol, Exacerbates Imiquimod-Induced Psoriasis-like Dermatitis in Steatohepatitic Mice.

International journal of molecular sciences·2022
Same author

Pemafibrate suppresses NLRP3 inflammasome activation in the liver and heart in a novel mouse model of steatohepatitis-related cardiomyopathy.

Scientific reports·2022
Same author

Predictive value of cytokeratin-18 fragment levels for diagnosing steatohepatitis in patients with nonalcoholic fatty liver disease.

European journal of gastroenterology & hepatology·2021
Same author

Dietary Oxysterol, 7-Ketocholesterol Accelerates Hepatic Lipid Accumulation and Macrophage Infiltration in Obese Mice.

Frontiers in endocrinology·2021
Same author

Infection phase is a predictor of pruritus in patients with hepatitis B virus infection.

Biomedical reports·2019
Same author

Overexpression of PODXL/ITGB1 and BCL7B/ITGB1 accurately predicts unfavorable prognosis compared to the TNM staging system in postoperative pancreatic cancer patients.

PloS one·2019
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Area of Science:

  • Hepatology
  • Pathology
  • Toxicology

Context:

  • Steatohepatitis presents with specific pathological features including zone 3 hepatic steatosis, ballooned hepatocytes, Mallory bodies, and fibrosis.
  • Alcoholic hepatitis is a key example, but other conditions like obesity, diabetes, Wilson disease, and hepatitis C can show similar pathology.
  • Accurate differential diagnosis is crucial to exclude other diseases presenting with steatohepatitis-like features.

Purpose:

  • To review and categorize the potential pathways involved in the development of drug-induced steatohepatitis.
  • To propose outlines of the mechanisms underlying drug-induced steatohepatitis.

Summary:

  • Pathological hallmarks of steatohepatitis include zone 3-dominant steatosis, hepatocyte ballooning, Mallory bodies, fibrosis, and inflammation.

Related Experiment Videos

  • Differential diagnosis must exclude conditions such as obesity, diabetes mellitus, Wilson disease, and hepatitis C, which can mimic steatohepatitis.
  • This article categorizes four main pathways implicated in drug-induced steatohepatitis and discusses their proposed mechanisms.

    • Impact:

    • Provides a framework for understanding the diverse mechanisms of drug-induced liver injury leading to steatohepatitis.
    • Aids clinicians in the differential diagnosis of steatohepatitis by highlighting key pathological features and potential drug etiologies.
    • Contributes to the scientific understanding of steatohepatitis pathogenesis, potentially guiding future research and therapeutic strategies.